Education Library

This FAQ addresses thrombus formation and anticoagulation for blood-contacting medical devices, such as the Impella® heart pump.

A study of 21,848 non-emergent, high-risk patients who underwent PCI with PVADs, including Impella® heart pumps, demonstrates the PVAD patients had a lower rate of mortality and complications than patients who underwent PCI with IABPs.

Learn how to use the Impella repositioning sheath with guidewire access port to insert a 0.035” guidewire to maintain access to the arteriotomy.

This Impella® skills training video demonstrates the main functions of the Automated Impella Controller (AIC) and describes the components and display screens.

Gregg Stone, MD, and Duane Pinto, MD, host this panel discussion from SCAI 2021 of Protected PCI and diagnosis and treatment of high-risk and complex coronary disease.

Learn about Impella heart pumps and how to transport patients, monitor pump position and troubleshoot during patient transport.

Ziad Ali, MD, discusses his recently published paper “Standardizing the Definition and Analysis Methodology for Complete Coronary Artery Revascularization” published in JAHA.

Alex Truesdell, MD, provides a high-level overview of essential skills for performing complex and high-risk PCI at the CRT 2021 virtual annual symposium.

Manreet Kanwar, MD, introduces clinicians to the concepts of machine learning and artificial intelligence, and their potential clinical applications in research and patient outcomes.

Learn more about what hemolysis is, how it is measured, and how Impella® is designed to minimize hemolysis.

This Impella skills video demonstrates insertion of the Impella RP®.

Cindy Grines, MD, discusses the efficacy of extensive revascularization with Impella® in this presentation from the 2021 American College of Cardiology virtual scientific session. 

Ziad Ali, MD, presents a case study illustrating imaging-guided PCI in the context of high-risk Protected PCI at the CRT 2021 virtual annual symposium. 

Tim Balthazar, MD, discusses his paper reviewing timing, selection, positioning, and escalation decisions for managing patients with short-term mechanical circulatory support.

Gregg Stone, M.D., primary investigator in the PROTECT IV randomized controlled trial, discusses data supporting the use of mechanical circulatory support for high-risk PCI.